BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28948632)

  • 1. Circulating cell-free high mobility group AT-hook 2 mRNA as a detection marker in the serum of colorectal cancer patients.
    Sahengbieke S; Wang J; Li X; Wang Y; Lai M; Wu J
    J Clin Lab Anal; 2018 May; 32(4):e22332. PubMed ID: 28948632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of high mobility group A2 specific mRNA in the plasma of patients affected by epithelial ovarian cancer.
    Galdiero F; Romano A; Pasquinelli R; Pignata S; Greggi S; Vuttariello E; Bello AM; Calise C; Scaffa C; Pisano C; Losito NS; Fusco A; Califano D; Chiappetta G
    Oncotarget; 2015 Aug; 6(22):19328-35. PubMed ID: 25749380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating high mobility group AT-hook 2 and pleomorphic adenoma gene 1 in blood of patients with oral squamous cell carcinoma.
    Ren W; Gao L; Li F; Qiang C; Li S; Zheng J; Kong X; Deng J; Cai G; Zhang H; Zhou M; Zhi K
    J Oral Pathol Med; 2017 Nov; 46(10):998-1003. PubMed ID: 28650082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer.
    Wang H; Zhang X; Wang L; Zheng G; Du L; Yang Y; Dong Z; Liu Y; Qu A; Wang C
    J Surg Oncol; 2014 May; 109(6):574-9. PubMed ID: 24338523
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Gao X; Wang X
    Nucleosides Nucleotides Nucleic Acids; 2021; 40(8):821-828. PubMed ID: 34284697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.
    Liu TP; Huang CC; Yeh KT; Ke TW; Wei PL; Yang JR; Cheng YW
    Surg Oncol; 2016 Dec; 25(4):429-434. PubMed ID: 27262492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer.
    Fabjani G; Tong D; Wolf A; Roka S; Leodolter S; Hoecker P; Fischer MB; Jakesz R; Zeillinger R
    Oncol Rep; 2005 Sep; 14(3):737-41. PubMed ID: 16077985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
    Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
    Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers.
    Wang X; Liu X; Li AY; Chen L; Lai L; Lin HH; Hu S; Yao L; Peng J; Loera S; Xue L; Zhou B; Zhou L; Zheng S; Chu P; Zhang S; Ann DK; Yen Y
    Clin Cancer Res; 2011 Apr; 17(8):2570-80. PubMed ID: 21252160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of periostin may help identify patients with more aggressive colorectal cancer.
    Ben QW; Zhao Z; Ge SF; Zhou J; Yuan F; Yuan YZ
    Int J Oncol; 2009 Mar; 34(3):821-8. PubMed ID: 19212687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.
    Shen C; Hu L; Xia L; Li Y
    Jpn J Clin Oncol; 2008 Nov; 38(11):770-6. PubMed ID: 18845519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of cytokeratin-20-positive cells in preoperative and postoperative blood samples from colorectal cancer patients by real-time RT-PCR.
    Šamija I; Lukač J; Mubrin MK; Kirac I; Kovačević D; Kusić Z
    Int J Biol Markers; 2013 Jun; 28(2):174-81. PubMed ID: 23558939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls.
    Wang C; Yu J; Han Y; Li L; Li J; Li T; Qi P
    Oncotarget; 2016 Oct; 7(43):70769-70778. PubMed ID: 27683121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
    Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
    Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer.
    Wu J; Wang Y; Xu X; Cao H; Sahengbieke S; Sheng H; Huang Q; Lai M
    Carcinogenesis; 2016 May; 37(5):511-21. PubMed ID: 26964871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
    Wang JY; Wu CH; Lu CY; Hsieh JS; Wu DC; Huang SY; Lin SR
    World J Surg; 2006 Jun; 30(6):1007-13. PubMed ID: 16736329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of miR-194 Reverses HMGA2-driven Signatures in Colorectal Cancer.
    Chang HY; Ye SP; Pan SL; Kuo TT; Liu BC; Chen YL; Huang TC
    Theranostics; 2017; 7(16):3889-3900. PubMed ID: 29109785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-Type OATP1B3 mRNA in Extracellular Vesicles as a Promising Candidate for a Serum-Based Colorectal Cancer Biomarker.
    Morio H; Sun Y; Harada M; Ide H; Shimozato O; Zhou X; Higashi K; Yuki R; Yamaguchi N; Hofbauer JP; Guttmann-Gruber C; Anzai N; Akita H; Chiba K; Furihata T
    Biol Pharm Bull; 2018; 41(3):445-449. PubMed ID: 29491222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Utility of Cell Free High Mobility Group AT-hook 2 (HMGA2) as a Prognostic Biomarker in Liquid Biopsies of Oral Squamous Cell Carcinoma.
    Mahmood N; Mushtaq S; Jamal Q; Hanif M; Akhlaq H; Rehman DE; Awan R
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):407-412. PubMed ID: 33639654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.